Theralase Technologies Inc (TLTFF)

[was CUIN2]

Clinical Trial is listed on HC website.

Government of Canada
Search and menus
Search and menus
You are here:
HomeDrugs & Health ProductsDrug ProductsClinical Trials Database
Clinical trial information
From Health Canada

New search
Medical condition:
BLADDER CANCER
Study population:
ADULT FEMALE, ADULT MALE
Drug name:
TLD1433
Protocol title:
A PHASE IB TRIAL OF INTRAVESICAL PHOTODYNAMIC THERAPY IN PATIENTS WITH NON-MUSCLE INVASIVE BLADDER CANCER AT HIGH RISK OF PROGRESSION WHO ARE REFRACTORY TO THERAPY WITH BACILLUS CALMETTER-GUERIN (BCG) AND WHO ARE MEDICALLY UNFIT FOR OR REFUSE A CYSTECTOMY.
Protocol number:
TLD1433
Sponsor name:
THERALASE TECHNOLOGIES INC
Date of no objection letter:
2015-12-16
Control number:
189722
Trial status:
ONGOING
Date study started:
2016-12-08
Date study completed:
New search
Application information

Search tips
CTA terminology
Frequently asked questions
Related information

Drug product database

https://health-products.canada.ca/ctdb-bdec/search-recherche.do;jsessionid=2DB26640722BF56391640BC778863D08